{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:52:39Z","timestamp":1791582759494,"version":"4.3.4"},"reference-count":77,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":1,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunobiology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.imbio.2026.153214","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T14:53:13Z","timestamp":1783090393000},"page":"153214","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Interleukin 27 (IL-27) in gastrointestinal cancers: from dual roles in tumor immunity to immunotherapeutic opportunities"],"prefix":"10.1016","volume":"231","author":[{"given":"Sana","family":"Esmaeeli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.imbio.2026.153214_bb0005","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3892\/ol.2021.12926","article-title":"Association between the serum concentrations and mutational status of IL-8, IL-27 and VEGF and the expression levels of the hERG potassium channel gene in patients with colorectal cancer","volume":"22","author":"Abid","year":"2021","journal-title":"Oncol. Lett."},{"issue":"8","key":"10.1016\/j.imbio.2026.153214_bb0010","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1158\/2159-8290.CD-20-1628","article-title":"IL27 signaling serves as an immunologic checkpoint for innate cytotoxic cells to promote hepatocellular carcinoma","volume":"12","author":"Aghayev","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.imbio.2026.153214_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2025.167821","article-title":"The role of the tumor microenvironment and inflammatory pathways in driving drug resistance in gastric cancer: a systematic review and meta-analysis","author":"Albano","year":"2025","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.imbio.2026.153214_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2025.114683","article-title":"Chimeric antigen receptor (CAR)-NK cell therapy in gastrointestinal (GI) cancers; a new arena","author":"Alkhathami","year":"2025","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.imbio.2026.153214_bb0025","doi-asserted-by":"crossref","first-page":"1395921","DOI":"10.3389\/fimmu.2024.1395921","article-title":"IL-27 expression regulation and its effects on adaptive immunity against viruses","volume":"15","author":"Andres-Martin","year":"2024","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.imbio.2026.153214_bb0030","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.3390\/cancers15061650","article-title":"Role and potential of different T helper cell subsets in adoptive cell therapy","volume":"15","author":"Andreu-Sanz","year":"2023","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.imbio.2026.153214_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/biology9060126","article-title":"STAT3 pathway in gastric cancer: signaling, therapeutic targeting and future prospects","volume":"9","author":"Ashrafizadeh","year":"2020","journal-title":"Biology"},{"issue":"7","key":"10.1016\/j.imbio.2026.153214_bb0040","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s00109-007-0164-7","article-title":"The biology and therapeutic potential of interleukin 27","volume":"85","author":"Batten","year":"2007","journal-title":"J. Mol. Med."},{"issue":"5","key":"10.1016\/j.imbio.2026.153214_bb0045","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.3390\/ijms23052419","article-title":"Proteolytic landscapes in gastric pathology and cancerogenesis","volume":"23","author":"Bernegger","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.imbio.2026.153214_bb0050","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41416-018-0328-y","article-title":"Cytokines in clinical cancer immunotherapy","volume":"120","author":"Berraondo","year":"2019","journal-title":"Br. J. Cancer"},{"issue":"3","key":"10.1016\/j.imbio.2026.153214_bb0055","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.jcmgh.2020.04.014","article-title":"Interleukin 27 protects from gastric atrophy and metaplasia during chronic autoimmune gastritis","volume":"10","author":"Bockerstett","year":"2020","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"issue":"4","key":"10.1016\/j.imbio.2026.153214_bb0060","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1582-4934.2005.tb00379.x","article-title":"Angiogenic and cell survival functions of vascular endothelial growth factor (VEGF)","volume":"9","author":"Byrne","year":"2005","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.imbio.2026.153214_bb0065","doi-asserted-by":"crossref","unstructured":"Chang K-K, Liu L-B, Jin L-P, Zhang B, Mei J, Li H, et al. IL-27 triggers IL-10 production in Th17 cells via a c-Maf\/ROR\u03b3t\/Blimp-1 signal to promote the progression of endometriosis. Cell Death Dis. 2017;8(3):e2666-e.","DOI":"10.1038\/cddis.2017.95"},{"issue":"8","key":"10.1016\/j.imbio.2026.153214_bb0070","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1136\/gutjnl-2018-317371","article-title":"NKp46 is a diagnostic biomarker and may be a therapeutic target in gastrointestinal T-cell lymphoproliferative diseases: a CELAC study","volume":"68","author":"Cheminant","year":"2019","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.imbio.2026.153214_bb0075","first-page":"518","article-title":"Adenovirus mediated expression of recombinant human single chain interleukin-27 (rhscIL-27) fusion gene in hepatoma cells","volume":"26","author":"Cheng","year":"2010","journal-title":"Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi"},{"issue":"5","key":"10.1016\/j.imbio.2026.153214_bb0080","first-page":"683","article-title":"Concentration of serum interleukin-27 increase in patients with lymph node metastatic gastroesophageal cancer","volume":"22","author":"Diakowska","year":"2013","journal-title":"Adv. Clin. Exp. Med."},{"issue":"1","key":"10.1016\/j.imbio.2026.153214_bb0085","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1074\/jbc.M111.294355","volume":"287","author":"Diegelmann","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"4_suppl","key":"10.1016\/j.imbio.2026.153214_bb0090","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1200\/jco.2012.30.4_suppl.228","article-title":"Comparative analysis of myeloid-derived suppressor cell (MDSC) subsets in patients with gastrointestinal (GI) malignancies","volume":"30","author":"Duffy","year":"2012","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.imbio.2026.153214_bb0095","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/MS9.0000000000002757","article-title":"Immunotherapy in gastrointestinal cancers: current strategies and future directions\u2013a literature review","volume":"87","author":"El Fil","year":"2025","journal-title":"Annals of medicine and surgery (2012)"},{"issue":"1","key":"10.1016\/j.imbio.2026.153214_bb0100","article-title":"Dual roles of IL-27 in cancer biology and immunotherapy","volume":"2017","author":"Fabbi","year":"2017","journal-title":"Mediators Inflamm."},{"issue":"1","key":"10.1016\/j.imbio.2026.153214_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4251\/wjgo.v13.i1.1","article-title":"Myeloid-derived suppressor cells in gastrointestinal cancers: a systemic review","volume":"13","author":"Farshidpour","year":"2021","journal-title":"World J. Gastrointest. Oncol."},{"key":"10.1016\/j.imbio.2026.153214_bb0110","doi-asserted-by":"crossref","first-page":"1032575","DOI":"10.3389\/fimmu.2022.1032575","article-title":"Type 1 regulatory T cell-mediated tolerance in health and disease","volume":"13","author":"Freeborn","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imbio.2026.153214_bb0115","doi-asserted-by":"crossref","unstructured":"Friedrich K, Dolznig H, Han X, Moriggl R. Steering of carcinoma progression by the YIN\/YANG interaction of STAT1\/STAT3. Biosci. Trends. 2017;11(1):1\u20138.","DOI":"10.5582\/bst.2016.01250"},{"issue":"12","key":"10.1016\/j.imbio.2026.153214_bb0120","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.mpdhp.2018.09.001","article-title":"Barrett\u2019s esophagus: a comprehensive review and update","volume":"24","author":"Gilani","year":"2018","journal-title":"Diagn. Histopathol."},{"key":"10.1016\/j.imbio.2026.153214_bb0125","article-title":"IL-27 expressed in the tumor microenvironment is correlated with PD-L1 levels and can induce PD-L1 expression on immune and tumor cells","author":"Golan","year":"2022","journal-title":"J. Immunother. Cancer"},{"issue":"1","key":"10.1016\/j.imbio.2026.153214_bb0130","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.immuni.2019.06.025","article-title":"Inflammation and cancer: triggers, mechanisms, and consequences","volume":"51","author":"Greten","year":"2019","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.imbio.2026.153214_bb0135","doi-asserted-by":"crossref","first-page":"474","DOI":"10.21037\/jgo.2017.05.01","article-title":"Immunotherapy in gastrointestinal cancers","volume":"8","author":"Grierson","year":"2017","journal-title":"J. Gastrointest. Oncol."},{"key":"10.1016\/j.imbio.2026.153214_bb0140","doi-asserted-by":"crossref","unstructured":"Haghighi H, Rava S, Haghshenas MR, Madani S, Ghaderi A, Fattahi MJ. Increased serum level of IL-27 and its clinical significance in patients with colorectal cancer. Res. Square [Preprint]. 2024.","DOI":"10.21203\/rs.3.rs-3973394\/v1"},{"issue":"2","key":"10.1016\/j.imbio.2026.153214_bb0145","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3390\/cancers13020210","article-title":"The functional crosstalk between myeloid-derived suppressor cells and regulatory T cells within the immunosuppressive tumor microenvironment","volume":"13","author":"Haist","year":"2021","journal-title":"Cancers"},{"issue":"22","key":"10.1016\/j.imbio.2026.153214_bb0150","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1182\/blood.V128.22.3343.3343","article-title":"IL-27 enhances inducible foxp3+ Treg function to prevent acute graft-versus-host disease lethality","volume":"128","author":"Hamilton","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.imbio.2026.153214_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106350","article-title":"IL-27 impact on NK cells activity: Implication for a robust anti-tumor response in chronic lymphocytic leukemia","volume":"82","author":"Hemati","year":"2020","journal-title":"Int. Immunopharmacol."},{"issue":"3","key":"10.1016\/j.imbio.2026.153214_bb0160","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1158\/0008-5472.CAN-03-2084","article-title":"Potent antitumor activity of interleukin-27","volume":"64","author":"Hisada","year":"2004","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.imbio.2026.153214_bb0165","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1111\/cas.13065","article-title":"An IL-27\/Stat3 axis induces expression of programmed cell death 1 ligands (PD-L1\/2) on infiltrating macrophages in lymphoma","volume":"107","author":"Horlad","year":"2016","journal-title":"Cancer Sci."},{"issue":"5","key":"10.1016\/j.imbio.2026.153214_bb0170","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/s41575-022-00726-3","article-title":"Updated epidemiology of gastrointestinal cancers in East Asia","volume":"20","author":"Huang","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.imbio.2026.153214_bb0175","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/intimm\/dxm139","article-title":"IL-27 inhibits the development of regulatory T cells via STAT3","volume":"20","author":"Huber","year":"2008","journal-title":"Int. Immunol."},{"key":"10.1016\/j.imbio.2026.153214_bb0180","doi-asserted-by":"crossref","first-page":"138","DOI":"10.4103\/2394-4722.166994","article-title":"Chronic inflammation and gastrointestinal cancer","volume":"1","author":"Ida","year":"2015","journal-title":"J. Cancer Metast. Treatm."},{"issue":"2","key":"10.1016\/j.imbio.2026.153214_bb0185","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.3390\/ijms16022851","article-title":"Interleukin-27 in T cell immunity","volume":"16","author":"Iwasaki","year":"2015","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.imbio.2026.153214_bb0190","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00005-010-0098-6","article-title":"Interleukin-27: biological properties and clinical application","volume":"58","author":"Jankowski","year":"2010","journal-title":"Arch. Immunol. Ther. Exp. (Warsz.)"},{"key":"10.1016\/j.imbio.2026.153214_bb0195","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2147\/ITT.S282466","article-title":"All are equal, some are more equal: targeting IL 12 and 23 in IBD\u2013a clinical perspective","author":"Jefremow","year":"2020","journal-title":"ImmunoTargets Ther."},{"issue":"5","key":"10.1016\/j.imbio.2026.153214_bb0200","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-010341","article-title":"Novel oncolytic vaccinia virus armed with interleukin-27 is a potential therapeutic agent for the treatment of murine pancreatic cancer","volume":"13","author":"Jia","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.imbio.2026.153214_bb0205","first-page":"167","article-title":"Immunotherapy in gastrointestinal cancers: current insights","author":"Jiang","year":"2025","journal-title":"Clin. Pharmacol.: Adv. Appl."},{"issue":"10","key":"10.1016\/j.imbio.2026.153214_bb0210","doi-asserted-by":"crossref","first-page":"8572","DOI":"10.18632\/aging.205825","article-title":"IL27 and IL1RN are causally associated with acute pancreatitis: a Mendelian randomization study","volume":"16","author":"Jing","year":"2024","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.imbio.2026.153214_bb0215","doi-asserted-by":"crossref","first-page":"969","DOI":"10.3389\/fonc.2019.00969","article-title":"IL-27, IL-30, and IL-35: a cytokine triumvirate in cancer","volume":"9","author":"Kourko","year":"2019","journal-title":"Front. Oncol."},{"issue":"5","key":"10.1016\/j.imbio.2026.153214_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2025.112308","article-title":"Interferon-\u03b3 and IL-27 positively regulate type 1 regulatory T cell development during adaptive tolerance","volume":"28","author":"Lecky","year":"2025","journal-title":"iScience"},{"key":"10.1016\/j.imbio.2026.153214_bb0225","article-title":"A randomized phase 2 study of casdozokitug, an IL-27 targeting antibody, in combination with toripalimab plus bevacizumab in patients with unresectable and\/or locally advanced or metastatic hepatocellular carcinoma","author":"Li","year":"2025","journal-title":"Am. Soc. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.imbio.2026.153214_bb0230","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2217\/imt.14.95","article-title":"The Yin and Yang aspects of IL-27 in induction of cancer-specific T-cell responses and immunotherapy","volume":"7","author":"Li","year":"2015","journal-title":"Immunotherapy"},{"issue":"1","key":"10.1016\/j.imbio.2026.153214_bb0235","article-title":"Epstein-Barr Virus-Induced Gene 3 (EBI3) blocking leads to induce antitumor cytotoxic t lymphocyte response and suppress tumor growth in colorectal cancer by bidirectional reciprocal-regulation STAT3 signaling pathway","volume":"2016","author":"Liang","year":"2016","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.imbio.2026.153214_bb0240","doi-asserted-by":"crossref","unstructured":"Lin C-H, Chen M-C, Lin L-L, Christian DA, Min B, Hunter CA, et al. Gut epithelial IL-27 confers intestinal immunity through the induction of intraepithelial lymphocytes. J. Exp. Med. 2021;218(11):e20210021.","DOI":"10.1084\/jem.20210021"},{"key":"10.1016\/j.imbio.2026.153214_bb0245","doi-asserted-by":"crossref","first-page":"1598170","DOI":"10.3389\/fonc.2025.1598170","article-title":"Dual regulation of gastrointestinal tumor progression by the IFN-\u03b3\/STAT1 pathway and prospects for targeted therapy","volume":"15","author":"Liu","year":"2025","journal-title":"Front. Oncol."},{"issue":"5","key":"10.1016\/j.imbio.2026.153214_bb0250","first-page":"470","article-title":"The role of IL-27 in the induction of anti-tumor cytotoxic T lymphocyte response","volume":"5","author":"Liu","year":"2013","journal-title":"Am. J. Transl. Res."},{"issue":"1","key":"10.1016\/j.imbio.2026.153214_bb0255","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s10238-025-01562-w","article-title":"Harnessing IL-27: challenges and potential in cancer immunotherapy","volume":"25","author":"Maleki","year":"2025","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.imbio.2026.153214_bb0260","article-title":"Gastric cancer\u2014Epidemiology, modifiable and non-modifiable risk factors, challenges and opportunities: an updated review","volume":"41","author":"Mamun","year":"2024","journal-title":"Cancer Treatm. Res. Commun."},{"issue":"1","key":"10.1016\/j.imbio.2026.153214_bb0265","article-title":"A pivotal role for interleukin-27 in CD8+ T cell functions and generation of cytotoxic T lymphocytes","volume":"2010","author":"Morishima","year":"2010","journal-title":"Biomed. Res. Int."},{"issue":"5","key":"10.1016\/j.imbio.2026.153214_bb0270","doi-asserted-by":"crossref","first-page":"S-64","DOI":"10.1016\/S0016-5085(14)60228-6","article-title":"269 EBI3 (IL-27\/IL-35) regulates the progression from atrophic gastritis to gastric cancer by regulating IL-17 production in the gastric mucosa","volume":"146","author":"Nguyen","year":"2014","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.imbio.2026.153214_bb0275","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.pan.2023.05.001","article-title":"Risk of pancreatic cancer after acute pancreatitis: a population-based matched cohort study","volume":"23","author":"Park","year":"2023","journal-title":"Pancreatology"},{"issue":"8","key":"10.1016\/j.imbio.2026.153214_bb0280","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1073\/pnas.1810254116","article-title":"IL-27 confers a protumorigenic activity of regulatory T cells via CD39","volume":"116","author":"Park","year":"2019","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.imbio.2026.153214_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.137113","article-title":"Development of interleukin-27 recombinant Lactococcus lactis and its efficacy in treating psoriasis and colitis in mice","volume":"282","author":"Qian","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"issue":"1","key":"10.1016\/j.imbio.2026.153214_bb0290","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1053\/j.gastro.2013.03.052","article-title":"The gastrointestinal tumor microenvironment","volume":"145","author":"Quante","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.imbio.2026.153214_bb0295","doi-asserted-by":"crossref","unstructured":"Rausch M, Moodley D, Peluso M, Koseoglu S, Hua J, Tan G, et al. 727 increased serum levels of EBI3 are associated with poor outcome in hepatocellular carcinoma patients and SRF388, a first-in-class IL-27 blocking antibody, inhibits the growth of murine liver tumors. J. Immunother. Cancer 2020;8(Suppl 3):A435-A.","DOI":"10.1136\/jitc-2020-SITC2020.0727"},{"issue":"1","key":"10.1016\/j.imbio.2026.153214_bb0300","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12667","article-title":"Interleukin-27 is abrogated in gastric cancer, but highly expressed in other Helicobacter pylori-associated gastroduodenal diseases","volume":"25","author":"Rocha","year":"2020","journal-title":"Helicobacter"},{"issue":"9252","key":"10.1016\/j.imbio.2026.153214_bb0305","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0140-6736(00)03630-8","article-title":"Relation between colitis and colon cancer","volume":"357","author":"Shanahan","year":"2001","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.imbio.2026.153214_bb0310","first-page":"243","article-title":"Diverse Molecular Mechanisms for Immune Evasion in Gastrointestinal Cancer","volume":"49","author":"Shibata","year":"2022","journal-title":"Gan to Kagaku ryoho Cancer Chemother."},{"issue":"1","key":"10.1016\/j.imbio.2026.153214_bb0315","doi-asserted-by":"crossref","first-page":"266","DOI":"10.4049\/jimmunol.1004182","article-title":"A role for IL-27 in limiting T regulatory cell populations","volume":"187","author":"Tait Wojno","year":"2011","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.imbio.2026.153214_bb0320","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1007\/s00432-012-1269-0","article-title":"Associations between polymorphisms in IL-12A, IL-12B, IL-12R\u03b21, IL-27 gene and serum levels of IL-12p40, IL-27p28 with esophageal cancer","volume":"138","author":"Tao","year":"2012","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.imbio.2026.153214_bb0325","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/s41392-025-02280-1","article-title":"Immune evasion in cancer: mechanisms and cutting-edge therapeutic approaches","volume":"10","author":"Tufail","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"issue":"22","key":"10.1016\/j.imbio.2026.153214_bb0330","doi-asserted-by":"crossref","first-page":"R760","DOI":"10.1016\/S0960-9822(02)01286-1","article-title":"Interleukin signaling","volume":"12","author":"Vo\u00dfhenrich","year":"2002","journal-title":"Curr. Biol."},{"issue":"4","key":"10.1016\/j.imbio.2026.153214_bb0335","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/s41388-020-01561-z","article-title":"The role of natural killer cell in gastrointestinal cancer: killer or helper","volume":"40","author":"Wang","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.imbio.2026.153214_bb0340","first-page":"601","article-title":"In vitro study on anti-esophageal cancer immunity induced by antigen-sensitized and interleukin 27 gene-modified dendritic cells","author":"Wang","year":"2011","journal-title":"Tumor"},{"issue":"3","key":"10.1016\/j.imbio.2026.153214_bb0345","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S2468-1253(23)00366-7","article-title":"Global, regional, and national lifetime risks of developing and dying from gastrointestinal cancers in 185 countries: a population-based systematic analysis of GLOBOCAN","volume":"9","author":"Wang","year":"2024","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.imbio.2026.153214_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2023.121364","article-title":"Materials and structure of polysaccharide-based delivery carriers for oral insulin: a review","volume":"323","author":"Wang","year":"2024","journal-title":"Carbohydr. Polym."},{"issue":"1","key":"10.1016\/j.imbio.2026.153214_bb0355","doi-asserted-by":"crossref","first-page":"3500","DOI":"10.1038\/s41467-021-23864-9","article-title":"WSX1 act as a tumor suppressor in hepatocellular carcinoma by downregulating neoplastic PD-L1 expression","volume":"12","author":"Wu","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.imbio.2026.153214_bb0360","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.cyto.2015.12.003","article-title":"Interleukin-27 inhibits malignant behaviors of pancreatic cancer cells by targeting M2 polarized tumor associated macrophages","volume":"89","author":"Yao","year":"2017","journal-title":"Cytokine"},{"key":"10.1016\/j.imbio.2026.153214_bb0365","doi-asserted-by":"crossref","first-page":"1344328","DOI":"10.3389\/fonc.2023.1344328","article-title":"The role of microbiomes in gastrointestinal cancers: new insights","volume":"13","author":"Yarahmadi","year":"2024","journal-title":"Front. Oncol."},{"issue":"12","key":"10.1016\/j.imbio.2026.153214_bb0370","doi-asserted-by":"crossref","DOI":"10.3390\/biom14121489","article-title":"Interleukin-27 and autoimmune disorders: a compressive review of immunological functions","volume":"14","author":"Yazdanpanah","year":"2024","journal-title":"Biomolecules"},{"issue":"16_Supplement","key":"10.1016\/j.imbio.2026.153214_bb0375","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1158\/1538-7445.AM2020-1050","article-title":"Serum interleukin-27 serves as an early biomarker predicting development of hepatocellular carcinoma (HCC) in two large prospective cohorts","volume":"80","author":"Yuan","year":"2020","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.imbio.2026.153214_bb0380","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1007\/s00109-025-02574-5","article-title":"CD8+ T Cells in Gastrointestinal Cancer: a Perspective on Targeting MicroRNA","volume":"103","author":"Yuan","year":"2025","journal-title":"J. Mol. Med."},{"issue":"12","key":"10.1016\/j.imbio.2026.153214_bb0385","doi-asserted-by":"crossref","first-page":"e404","DOI":"10.1097\/TP.0000000000005069","article-title":"Interleukin-27 promotes the generation of myeloid-derived suppressor cells to alleviate graft-versus-host disease","volume":"108","author":"Zhu","year":"2024","journal-title":"Transplantation"}],"container-title":["Immunobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298526000604?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298526000604?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:06:55Z","timestamp":1791580015000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0171298526000604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":77,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0171298526000604"],"URL":"https:\/\/doi.org\/10.1016\/j.imbio.2026.153214","relation":{},"ISSN":["0171-2985"],"issn-type":[{"value":"0171-2985","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interleukin 27 (IL-27) in gastrointestinal cancers: from dual roles in tumor immunity to immunotherapeutic opportunities","name":"articletitle","label":"Article Title"},{"value":"Immunobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imbio.2026.153214","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"153214"}}